Skip to Content
Merck
CN
  • Repeat expansions confer WRN dependence in microsatellite-unstable cancers.

Repeat expansions confer WRN dependence in microsatellite-unstable cancers.

Nature (2020-10-02)
Niek van Wietmarschen, Sriram Sridharan, William J Nathan, Anthony Tubbs, Edmond M Chan, Elsa Callen, Wei Wu, Frida Belinky, Veenu Tripathi, Nancy Wong, Kyla Foster, Javad Noorbakhsh, Kiran Garimella, Abimael Cruz-Migoni, Joshua A Sommers, Yongqing Huang, Ashir A Borah, Jonathan T Smith, Jeremie Kalfon, Nikolas Kesten, Kasper Fugger, Robert L Walker, Egor Dolzhenko, Michael A Eberle, Bruce E Hayward, Karen Usdin, Catherine H Freudenreich, Robert M Brosh, Stephen C West, Peter J McHugh, Paul S Meltzer, Adam J Bass, André Nussenzweig
ABSTRACT

The RecQ DNA helicase WRN is a synthetic lethal target for cancer cells with microsatellite instability (MSI), a form of genetic hypermutability that arises from impaired mismatch repair1-4. Depletion of WRN induces widespread DNA double-strand breaks in MSI cells, leading to cell cycle arrest and/or apoptosis. However, the mechanism by which WRN protects MSI-associated cancers from double-strand breaks remains unclear. Here we show that TA-dinucleotide repeats are highly unstable in MSI cells and undergo large-scale expansions, distinct from previously described insertion or deletion mutations of a few nucleotides5. Expanded TA repeats form non-B DNA secondary structures that stall replication forks, activate the ATR checkpoint kinase, and require unwinding by the WRN helicase. In the absence of WRN, the expanded TA-dinucleotide repeats are susceptible to cleavage by the MUS81 nuclease, leading to massive chromosome shattering. These findings identify a distinct biomarker that underlies the synthetic lethal dependence on WRN, and support the development of therapeutic agents that target WRN for MSI-associated cancers.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
MISSION® esiRNA, targeting human WRN